Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
Overwhelming shareholder support in favour of take-private transaction with Aditxt Studies presented…
Invivyd Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 14, 2024 07:05 ET | Source: Invivyd Q3 2024 PEMGARDA™ (pemivibart)…
Breakthrough Research Presented in Scientific Reports Demonstrates How Gene-Edited Microbes Offer a New Source of Nitrogen to Farmers
Findings are the first, peer-reviewed evidence of gene-edited microbes supplying a material…
dLocal Reports 2024 Third Quarter Financial Results
Third Quarter 2024Robust TPV growth, up 41% YoY and 8% QoQ, driven…
Worldwide English Proficiency Index Reports Persistent Global Decline With Weaker Skills in Women and Young adults
ZURICH, Nov. 13, 2024 /PRNewswire/ -- EF Education First (EF), a global provider of…
Ellington Credit Company Reports Third Quarter 2024 Results
OLD GREENWICH, Conn.--(BUSINESS WIRE)--Ellington Credit Company (NYSE: EARN) ("we", "us," or "our")…
Bioceres Crop Solutions Reports Fiscal First Quarter 2025 Financial and Operational Results
Total revenues in 1Q25 were $93.3 million 1Q25 net loss1 was $5.3…
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on…
Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates
JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX),…
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 07, 2024 16:30 ET | Source: BioAge Labs, Inc. Initiated Phase…